NYU Grossman School of Medicine

10/19/2026

Why do some people benefit more than others from hypoglossal nerve stimulation for obstructive sleep apnea?

Courtney Chou, MD, a sleep surgeon at NYU Langone Health, is exploring better ways to measure treatment response beyond traditional metrics. By considering factors such as reduced oxygen-related strain during sleep and overall disease improvement, clinicians can better understand outcomes and have more meaningful conversations with patients.

10/16/2026

When a hip fracture doesn’t heal as expected, persistent pain and loss of mobility can make treatment more complex.

A recent case from the orthopedic surgery team at NYU Langone Health highlights a hip-preserving approach for an older patient with intertrochanteric fracture nonunion.

Rather than moving directly to joint replacement, the team used reconstructive surgery to correct the deformity, stabilize the fracture, and support healing.

The patient ultimately regained mobility without conversion to complex hip arthroplasty, underscoring how femoral head-preserving surgery may be an option for carefully selected patients.

Read more ⤵️

Drs. Kenneth Egol and Steven Rivero of NYU Langone Orthopedics discuss femoral head-preserving surgery for a patient with an intertrochanteric hip fracture nonunion. Learn more.

10/14/2026

At NYU Grossman School of Medicine, medical training is quickly evolving alongside new AI tools reshaping clinical practice.

That shift is at the heart of a new JAMA Viewpoint from Jesse Burk-Rafel, MD, MRes, assistant director of our Institute for Innovations in Medical Education. As AI becomes more capable, he argues that medical training should place less emphasis on rote memorization and more on clinical reasoning and communication at the bedside. Future physicians will also need formal training in how to evaluate AI recommendations—and when to override them.

Read his new JAMA Network Viewpoint with co-author Dr. Robert Wachter of UC San Francisco: https://bit.ly/4ym8gxo

10/12/2026

For neuroscientist Ariel Hight, PhD, the questions driving his research are deeply personal.

Born deaf, Dr. Hight received his first cochlear implant at age 3 and his second in his mid 20s. Experiencing how his own brain learned to interpret sound helped shape his scientific interest in how the brain adapts to cochlear implants.

Now a postdoctoral fellow at NYU Grossman School of Medicine, Dr. Hight works alongside Robert C. Froemke, PhD, and J. Thomas Roland Jr., MD, to investigate the biological processes that help cochlear implant users interpret electrical signals as sound and whether that adaptation can be accelerated.

In the newest episode of Behind the Breakthrough, learn how Dr. Hight’s lived experience is helping shape research aimed at improving how people hear.

Watch the full episode to learn more ➡️ https://www.youtube.com/watch?v=-Uq-KssJu2E

10/10/2026

Can a few practical steps help more people get screened for colorectal cancer?

Dr. Aasma Shaukat, a gastroenterologist and professor of medicine at NYU Grossman School of Medicine, is sharing her research at the Presidential Plenary of the American College of Gastroenterology (ACG) Annual Scientific Meeting.

Her team randomly assigned patients at community health centers across Brooklyn to one of two study groups. The first group received standard care. The second received added support, including health information in their preferred language, an at-home stool test kit sent by mail, and phone reminders. Patients in the second group also received one-on-one help completing screening and a follow-up colonoscopy if needed.

The result: screening rates rose by 16 percent in the second group.

Dr. Shaukat says community health centers nationwide could build these steps into everyday care to help more patients get screened.

10/09/2026

Colorectal cancer screening is changing. Here's what to know. 👇

Dr. Aasma Shaukat, a gastroenterologist and professor of medicine at NYU Grossman School of Medicine, shares three key updates from the American College of Gastroenterology (ACG) Annual Scientific Meeting:
• Screening starts at age 45 for average-risk men and women in the U.S.
• Colonoscopy and stool-based tests are the primary screening options.
• Newer blood-based tests may help reach people who haven't been screened.

10/09/2026

Less than 5 percent. That's how much of the corneal endothelium standard specular microscopy can capture.

This single layer of cells keeps the cornea clear. Clinicians assess it in Fuchs dystrophy, before cataract surgery, and after corneal transplantation. Yet the periphery remains the hardest part to image.

Ved Shivade, MS, and his team at NYU Grossman School of Medicine, in partnership with Case Western Reserve University, built Tessera, custom software that takes video from a widefield microscope and stitches the frames into one large, detailed mosaic in real time.

Technicians can watch the image build, spot any gaps, and recapture them before the session ends. In early results, Tessera mosaics covered up to 75 percent of the endothelium—137 to 254 times more area than a single frame. One mosaic mapped 62,595 cells. That's the largest cell count from a single endothelial image reported to date.

A wider view could help researchers track corneal health, disease progression, and responses to emerging therapies over time.

Ved Shivade, MS, explains how it works. Watch.

10/01/2026

A rare vascular condition present at birth can sometimes affect more than the skin.

In one newborn with cutis marmorata telangiectatica congenita, specialists at NYU Langone Health identified serious retinal involvement early enough to intervene before permanent vision loss occurred.

Vaidehi S. Dedania, MD used fluorescein angiography to confirm the extent of the eye disease and treated both eyes with laser photocoagulation. Follow-up testing showed the retinal traction had resolved, and vision was preserved.

The case underscores why infants born with this condition should receive prompt ophthalmic evaluation, especially when early treatment can prevent retinal detachment and protect sight.

Learn more ⤵️

NYU Langone retina specialist Dr. Vaidehi S. Dedania performed laser eye surgery in a days-old infant, preventing retinal detachment and saving the child’s sight. Learn more.

09/28/2026

For patients with pe**le cancer, spread to the inguinal lymph nodes can significantly shape treatment decisions.

A recent case from Jamie Pak, MD, and the urology team at NYU Langone Health highlights how robotic surgery paired with fluorescence imaging can help surgeons navigate complex lymphatic anatomy with greater precision.

Rather than relying on a traditional open approach, the team used near-infrared lymphangiography to visualize lymphatic pathways during surgery and support targeted removal of disease.

The patient recovered without postoperative complications, and early follow-up imaging showed no evidence of metastatic disease.

The case offers a closer look at how minimally invasive techniques may continue to evolve the surgical management of nodal disease in pe**le cancer.

Click to read more ⤵️

NYU Langone’s Dr. Jamie Pak details his approach to robotic bilateral inguinal lymph node dissection for nodal metastasis in pe**le cancer. Learn more.

09/26/2026

From four hours a day on the rings as a Stanford gymnast to training for a career in medicine, Mark Berlaga’s journey to NYU Grossman School of Medicine has taught him the value of discipline, teamwork, and showing up for others.

As a Division I athlete, Mark learned that success was never an individual pursuit. His experiences on the gymnastics team, along with injuries that introduced him to the doctors and therapists who helped him return to competition, sparked his interest in medicine.

That calling became clear during an EMT ride-along, when Mark helped care for a patient in cardiac arrest. “I knew I wanted to be part of the team that gets people back to doing what they love.”

Now, Mark is bringing that team-first mindset to NYU Grossman as he begins his journey as a physician. Welcome Mark!